Discussion Topic: Atrial Fibrillation Progression after Cryoablation versus Radiofrequency Ablation: The CIRCA-DOSE Trial
Janice Y. Chyou, MD, FHRS, Icahn School of Medicine at Mount Sinai, is joined by Fred M. Kusumoto, MD, FHRS, Mayo Clinic Jacksonville, and Julia H. Indik, MD, PhD, FHRS, University of Arizona Medical Center (CVD) to discuss how Atrial fibrillation (AF) is a chronic progressive disorder. Persistent forms of AF are associated with increased rates of thromboembolism, heart failure, and death. Catheter ablation modifies the pathogenic mechanism of AF progression. No randomized studies have evaluated the impact of the ablation energy on progression to persistent atrial tachyarrhythmia.
Host: Janice Y. Chyou, MD, FHRS
Guests: Fred M. Kusumoto, MD, FHRS and Julia H. Indik, MD, PhD, FHRS
Speaker and Article Information: Download
Topic
- The Lead
Resource Type
- Podcasts
Related Resources
The Lead
Podcasts
The Lead Episode 131: A Discussion of Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial (Japanese Language Episode)
January 8, 2026
The Lead
Podcasts
The Lead Episode 131: A Discussion of Caffeinated Coffee Consumption or Abstinence to Reduce Atrial Fibrillation: The DECAF Randomized Clinical Trial (English Language Episode)
January 8, 2026
HRX Next
Podcasts
HRX NeXt Ep. 5 – A Conversation About What AI is and Why Clinicians Should Care
January 7, 2026